Search
01/01/2022
Actualización y validación del riesgo cardiovascular de por vida en España: IBERLIFERISK2
Brotons C., Moral-Peláez I., Vicuña J., Ameixeiras C., Fernández-Lavandera C., Sánchez-Chaparro M.Á.. Actualización y validación del riesgo cardiovascular de por vida en España: IBERLIFERISK2. Clinica E Investigacion En Arteriosclerosis. 2022; 35(3)DOI:10.1016/j.arteri.2022.09.003. PMID:36344347. IF:(Q/D).
01/01/2022
La complejidad del papel del colesterol unido a HDL
Brotons C., Moral I., Vicuña J.. La complejidad del papel del colesterol unido a HDL. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 76(2)DOI:10.1016/j.recesp.2022.08.004. PMID:36228961. IF:5.900(Q1/3D).
01/01/2022
Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS
Orozco-Beltrán D., Brotons Cuixart C., Banegas Banegas J.R., Gil Guillén V.F., Cebrián Cuenca A.M., Martín Rioboó E., Jordá Baldó A., Vicuña J., Navarro Pérez J.. Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS. Atencion Primaria. 2022; 54(Suppl 1)DOI:10.1016/j.aprim.2022.102444. PMID:36435583. IF:(Q/D).
01/01/2022
Effects of a Digital Patient Empowerment and Communication Tool on Metabolic Control in People With Type 2 Diabetes: The DeMpower Multicenter Ambispective Study
Orozco-Beltrán D., Morales C., Artola-Menéndez S., Brotons C., Carrascosa S., González C., Baro Ó., Aliaga A., de Campos K.F., Villarejo M., Hurtado C., Álvarez-Ortega C., Gómez-García A., Cedenilla M., Fernández G.. Effects of a Digital Patient Empowerment and Communication Tool on Metabolic Control in People With Type 2 Diabetes: The DeMpower Multicenter Ambispective Study. Jmir Diabetes. 2022; 7(4)DOI:10.2196/40377. PMID:. IF:(Q/D).
01/01/2022
Sociodemographic determinants of intraurban variations in COVID-19 incidence: the case of Barcelona
Lopez-Gay, A, Spijker, J, Cole, HVS, Marques, AG, Triguero-Mas, M, Anguelovski, I, Mari-Dell'Olmo, M, Modenes, JA, Alamo-Junquera, D, Lopez-Gallego, F, Borrell, C. Sociodemographic determinants of intraurban variations in COVID-19 incidence: the case of Barcelona. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH. 2022; 76(1)DOI:10.1136/jech-2020-216325. PMID:34158409. IF:6.300(Q1/2D).
01/01/2022
Insight on how to assess and improve the response to the COVID-19 pandemic
Martín-Moreno J.M., Arenas A., Bengoa R., Borrell C., Franco M., García-Basteiro A.L., Gestal J., González López-Valcárcel B., Hernández Aguado I., Legido-Quigley H., March J.C., Minué S., Muntaner C., Vives-Cases C.. Insight on how to assess and improve the response to the COVID-19 pandemic. Gaceta Sanitaria. 2022; 36(1)DOI:10.1016/j.gaceta.2020.11.008. PMID:33518411. IF:1.900(Q3/8D).
01/01/2022
Pediatric Medication Noninitiation in Spain
Carbonell-Duacastella C., Rubio-Valera M., Marqués-Ercilla S., Peñarrubia-María M.T., Gil-Girbau M., Garcia-Cardenas V., Pasarín M.I., Parody-Rúa E., Aznar-Lou I.. Pediatric Medication Noninitiation in Spain. PEDIATRICS. 2022; 149(1)DOI:10.1542/peds.2020-034371. PMID:34957504. IF:8.000(Q1/1D).
01/01/2022
Healthier and more sustainable school canteens to combat the climate emergency
Vaquero, PR, Alasa, MB, Martinez, OJ, Sanfeliu, LM, Rua, MIP, Arciniega, NS, Genovart, MB. Healthier and more sustainable school canteens to combat the climate emergency. Nutricion Clinica Y Dietetica Hospitalaria. 2022; 42(3)DOI:10.12873/423ramos. PMID:. IF:(Q/D).